scemblix
novartis europharm limited - asciminib hydrochloride - leukemi, myelogen, kronisk, bcr-abl positiv - antineoplastiska medel - scemblix is indicated for the treatment of adult patients with philadelphia chromosome positive chronic myeloid leukaemia in chronic phase (ph+ cml cp) previously treated with two or more tyrosine kinase inhibitors (see section 5.
sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastiska medel - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
axitinib stada 5 mg filmdragerad tablett
stada arzneimittel ag - axitinib - filmdragerad tablett - 5 mg - axitinib 5 mg aktiv substans; laktosmonohydrat hjälpämne
axitinib stada 3 mg filmdragerad tablett
stada arzneimittel ag - axitinib - filmdragerad tablett - 3 mg - axitinib 3 mg aktiv substans; laktosmonohydrat hjälpämne
axitinib stada 7 mg filmdragerad tablett
stada arzneimittel ag - axitinib - filmdragerad tablett - 7 mg - axitinib 7 mg aktiv substans; laktosmonohydrat hjälpämne
sunitinib teva 12,5 mg kapsel, hård
teva b.v. - sunitinib - kapsel, hård - 12,5 mg - sunitinib 12,5 mg aktiv substans; propylenglykol hjälpämne; mannitol hjälpämne
sunitinib teva 50 mg kapsel, hård
teva b.v. - sunitinib - kapsel, hård - 50 mg - sunitinib 50 mg aktiv substans; propylenglykol hjälpämne; mannitol hjälpämne
sunitinib sandoz 37,5 mg kapsel, hård
sandoz a/s - sunitinib - kapsel, hård - 37,5 mg - sunitinib 37,5 mg aktiv substans; mannitol hjälpämne; propylenglykol hjälpämne
sunitinib medical valley 37,5 mg kapsel, hård
medical valley invest ab - sunitinibmalat - kapsel, hård - 37,5 mg - sunitinibmalat 50,1 mg aktiv substans; mannitol hjälpämne; propylenglykol hjälpämne; tartrazin hjälpämne; para-orange hjälpämne
sunitinib zentiva 50 mg kapsel, hård
zentiva k.s. - sunitinib - kapsel, hård - 50 mg - sunitinib 50 mg aktiv substans; mannitol hjälpämne; propylenglykol hjälpämne